Prevalence of Nonalcoholic Fatty Liver Disease in the Middle Eastern Area: What Is the Exact Estimation?

Prevalence of Nonalcoholic Fatty Liver Disease in the Middle Eastern Area: What Is the Exact Estimation? Publisher Pubmed

Naderian M¹ ; Ebrahimi H¹ ; Sohrabpour AA¹

Show Affiliations

1. The Liver, Pancreatic, and Biliary Diseases Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Hepatology Published:2016

Abstract

[No abstract available]

2. Green Cardamom Increases Sirtuin-1 and Reduces Inflammation in Overweight or Obese Patients With Non-Alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Clinical Trial, Nutrition and Metabolism (2018)

3. Effects of Vitamin D Supplementation on Liver Fibrogenic Factors in Non-Alcoholic Fatty Liver Patients With Steatohepatitis: Study Protocol for a Randomized Clinical Trial, Trials (2019)

4. The Effects of Green Cardamom on Blood Glucose Indices, Lipids, Inflammatory Factors, Paraxonase-1, Sirtuin-1, and Irisin in Patients With Nonalcoholic Fatty Liver Disease and Obesity: Study Protocol for a Randomized Controlled Trial, Trials (2017)

5. A Population-Based Prospective Study on Obesity-Related Non-Communicable Diseases in Northern Iran: Rationale, Study Design, and Baseline Analysis, Frontiers in Endocrinology (2024)

6. Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease Among an Iranian Adult Population With Ethnic and Genetic Diversity: Results of the Polyiran-Liver Study, Middle East Journal of Digestive Diseases (2024)

7. Patients With Psoriasis Are at a Higher Risk of Developing Nonalcoholic Fatty Liver Disease, Clinical and Experimental Dermatology (2015)

8. Efficacy of Nanocurcumin Supplementation on Insulin Resistance, Lipids, Inflammatory Factors and Nesfatin Among Obese Patients With Non-Alcoholic Fatty Liver Disease (Nafld): A Trial Protocol, BMJ Open (2017)

Experts (# of related papers)

View all Related Experts

Hossein Poustchi (3)

Amir Reza Radmard (1)

Style	Citing Format
MLA	Naderian M, Ebrahimi H, Sohrabpour AA. "Prevalence of Nonalcoholic Fatty Liver Disease in the Middle Eastern Area: What Is the Exact Estimation?." Hepatology, vol. 64, no. 4, 2016, pp. 1390-1391.
APA	Naderian M, Ebrahimi H, Sohrabpour AA (2016). Prevalence of Nonalcoholic Fatty Liver Disease in the Middle Eastern Area: What Is the Exact Estimation?. Hepatology, 64(4), 1390-1391.
Chicago	Naderian M, Ebrahimi H, Sohrabpour AA. "Prevalence of Nonalcoholic Fatty Liver Disease in the Middle Eastern Area: What Is the Exact Estimation?." Hepatology 64, no. 4 (2016): 1390-1391.
Harvard	Naderian M, Ebrahimi H, Sohrabpour AA (2016) 'Prevalence of Nonalcoholic Fatty Liver Disease in the Middle Eastern Area: What Is the Exact Estimation?', Hepatology, 64(4), pp. 1390-1391.
Vancouver	Naderian M, Ebrahimi H, Sohrabpour AA. Prevalence of Nonalcoholic Fatty Liver Disease in the Middle Eastern Area: What Is the Exact Estimation?. Hepatology. 2016;64(4):1390-1391.
BibTex	@article{ author = {Naderian M and Ebrahimi H and Sohrabpour AA}, title = {Prevalence of Nonalcoholic Fatty Liver Disease in the Middle Eastern Area: What Is the Exact Estimation?}, journal = {Hepatology}, volume = {64}, number = {4}, pages = {1390-1391}, year = {2016} }
RIS	TY - JOUR AU - Naderian M AU - Ebrahimi H AU - Sohrabpour AA TI - Prevalence of Nonalcoholic Fatty Liver Disease in the Middle Eastern Area: What Is the Exact Estimation? JO - Hepatology VL - 64 IS - 4 SP - 1390 EP - 1391 PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract